Single reports delivered instantly via Stripe. Bundles invoiced within 2 hours.
27,818 behavioral health facilities scored across 51 states. Know which markets to enter before the consolidation window closes — ranked by acquisition opportunity with a Medicaid risk overlay that flags 2027 rate exposure before you deploy capital.
The AcuiteIQ Behavioral Health Report covers every private behavioral health facility in the United States, scored on a 100-point proprietary model built from SAMHSA N-SUMHSS 2024, HRSA Mental Health HPSA designations, CMS Medicare claims, and the NPPES national provider registry.
Each facility is assigned to one of four acquisition tiers based on market demand, facility fragmentation, and facility quality — giving your deal team a pre-sorted target list ready for Monday-morning outreach.
Critically, this is the only BH dataset that includes a Medicaid Exposure Risk Score — identifying which facilities carry policy risk from anticipated federal funding changes, and which are insulated by commercial revenue.
| # | State | Type | Acq. Score | Demand | Fragmentation | Facilities | Tier 1 Targets | Medicaid Risk |
|---|
Federal Medicaid funding changes anticipated in 2027–2028 create real reimbursement risk for facilities with concentrated public-payer revenue. AcuiteIQ's Medicaid Exposure Risk Score — included in the full report — flags every facility and state so you know what you're underwriting before you write the check.
No other BH dataset includes this signal. It's the difference between pricing risk in and being surprised at exit.
The US behavioral health services market is one of the largest and fastest-growing segments in healthcare — driven by post-COVID demand surges, mental health parity legislation, and accelerating destigmatization of treatment-seeking behavior.
Of 27,818 total facilities analyzed, 19,066 are privately owned and represent viable PE acquisition targets. The sector remains deeply fragmented — no single operator commands more than a few percent of national capacity.
Dual-diagnosis facilities — treating co-occurring substance use and mental health disorders — command premium valuations due to higher reimbursement rates, longer length of stay, and more defensible commercial payor relationships. AcuiteIQ flags these in the full dataset.
Based on our 2025 scoring, top-ranked states include New York, Missouri, California, Illinois, and Kentucky — where demand, private facility concentration, and market fragmentation converge. New York leads with an average acquisition score of 50.8 across 1,624 total facilities. Full 51-state rankings are in the complete report.
Four federal datasets: SAMHSA National Survey of Substance Abuse Treatment Services (N-SUMHSS) 2024 covering approximately 17,000 facilities with ownership, services, beds, clients, payer mix, and accreditation data; HRSA Mental Health HPSA Designations 2024; CMS Medicare Physician & Other Practitioners 2023; and the NPPES National Provider Registry (February 2026) providing 46,763 named independent targets with contact information.
The Medicaid Exposure Risk Score (0–100) measures each facility's and state's dependence on public-payer revenue. With anticipated federal Medicaid funding changes expected to affect reimbursement in 2027–2028, facilities with high exposure scores carry meaningful policy risk that could compress margins and valuations before exit. This score is unique to AcuiteIQ — no other BH dataset provides facility-level Medicaid risk flags.
Each facility receives a composite acquisition score (0–100) across market demand, fragmentation, and facility quality. Tier 1 (top 10%, 2,816 facilities) = highest priority targets with high demand, fragmented markets, and quality facilities. Tier 2 (next 25%) = strong targets where at least 2 of 3 components score high. Tier 3 = watch list for emerging markets. Tier 4 = lower priority, typically public facilities or low-demand markets.
SAMHSA's public locator tells you where facilities exist. AcuiteIQ tells you which ones to acquire, in what order, and what risk you're taking on. Our proprietary scoring model ranks every private facility by acquisition opportunity, overlays Medicaid risk, and delivers a ready-to-use outreach list — not a database you have to analyze yourself. It's the difference between raw data and actionable intelligence.
27,818 facilities scored. 2,816 Tier 1 targets identified. Medicaid risk mapped. One purchase, instant delivery.